相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CAR T cell therapy for multiple myeloma: where are we now and where are we headed?
Arnab Ghosh et al.
LEUKEMIA & LYMPHOMA (2018)
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
Terry J. Fry et al.
NATURE MEDICINE (2018)
Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses
Jang Hwan Cho et al.
CELL (2018)
Towards Molecular Profiling in Multiple Myeloma: A Literature Review and Early Indications of Its Efficacy for Informing Treatment Strategies
Wolfgang Willenbacher et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Disease Milestones through Bibliometric Analysis of the Top 100 Cited Articles in Multiple Myeloma
Azka Latif et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2018)
A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo
S. Hipp et al.
LEUKEMIA (2017)
Novel Immunotherapies for Multiple Myeloma
Mattia D'Agostino et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2017)
tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines
Dina Schneider et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth
Vita Golubovskaya et al.
CANCERS (2017)
T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma
Syed Abbas Ali et al.
BLOOD (2016)
Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors
Kole T. Roybal et al.
CELL (2016)
The novel anti-CD19 chimeric antigen receptors with humanized scFv (single-chain variable fragment) trigger leukemia cell killing
Liren Qian et al.
CELLULAR IMMUNOLOGY (2016)
Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection
Eugene A. Zhukovsky et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Anti-BCMA CAR T cells show promise in MM
Peter Sidaway
Nature Reviews Clinical Oncology (2016)
Construction of a new anti-CD19 chimeric antigen receptor and the anti-leukemia function study of the transduced T cells
Na An et al.
ONCOTARGET (2016)
T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
Eugenia Zah et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy
Vita Golubovskaya et al.
CANCERS (2016)
Efficiency of CD19 chimeric antigen receptor-modified T cells for treatment of B cell malignancies in phase I clinical trials: a meta-analysis
Tengfei Zhang et al.
ONCOTARGET (2015)
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation
James N. Kochenderfer et al.
BLOOD (2013)
Zoom Zoom: Racing CARs for Multiple Myeloma
Marcela V. Maus et al.
CLINICAL CANCER RESEARCH (2013)
B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma
Robert O. Carpenter et al.
CLINICAL CANCER RESEARCH (2013)
APRIL Binding to BCMA Activates a JNK2-FOXO3-GADD45 Pathway and Induces a G2/M Cell Growth Arrest in Liver Cells
George Notas et al.
JOURNAL OF IMMUNOLOGY (2012)
Combining CD19 Redirection and Alloanergization to Generate Tumor-Specific Human T Cells for Allogeneic Cell Therapy of B-Cell Malignancies
Jeff K. Davies et al.
CANCER RESEARCH (2010)
BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone
J Moreaux et al.
BLOOD (2004)
Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival
AJ Novak et al.
BLOOD (2004)
Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15
RJ Brentjens et al.
NATURE MEDICINE (2003)
TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-κB, Elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase
A Hatzoglou et al.
JOURNAL OF IMMUNOLOGY (2000)
APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity
G Yu et al.
NATURE IMMUNOLOGY (2000)
分享论文
